NL169182C - Werkwijze voor de bereiding van een geneesmiddel met hypotensieve werking en verlaagde sedatieve neveneffecten op basis van fluorbevattende arylmethylaminoderivaten en werkwijze voor de bereiding van geneeskrachtige fluorbevattende arylmethylaminoderivaten, geschikt voor gebruik daarbij. - Google Patents

Werkwijze voor de bereiding van een geneesmiddel met hypotensieve werking en verlaagde sedatieve neveneffecten op basis van fluorbevattende arylmethylaminoderivaten en werkwijze voor de bereiding van geneeskrachtige fluorbevattende arylmethylaminoderivaten, geschikt voor gebruik daarbij.

Info

Publication number
NL169182C
NL169182C NLAANVRAGE7705727,A NL7705727A NL169182C NL 169182 C NL169182 C NL 169182C NL 7705727 A NL7705727 A NL 7705727A NL 169182 C NL169182 C NL 169182C
Authority
NL
Netherlands
Prior art keywords
preparation
methylaminoderatives
fluoratic
fluoramethane
medicinally
Prior art date
Application number
NLAANVRAGE7705727,A
Other languages
English (en)
Other versions
NL7705727A (nl
NL169182B (nl
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of NL7705727A publication Critical patent/NL7705727A/nl
Publication of NL169182B publication Critical patent/NL169182B/nl
Application granted granted Critical
Publication of NL169182C publication Critical patent/NL169182C/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333Radicals substituted by oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/48Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/12Nitrogen atoms not forming part of a nitro radical
    • C07D239/14Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/061,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C07D265/081,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NLAANVRAGE7705727,A 1976-05-24 1977-05-24 Werkwijze voor de bereiding van een geneesmiddel met hypotensieve werking en verlaagde sedatieve neveneffecten op basis van fluorbevattende arylmethylaminoderivaten en werkwijze voor de bereiding van geneeskrachtige fluorbevattende arylmethylaminoderivaten, geschikt voor gebruik daarbij. NL169182C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7615601A FR2358890A1 (fr) 1976-05-24 1976-05-24 Nouvelles aryl trifluoroethylamines, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant

Publications (3)

Publication Number Publication Date
NL7705727A NL7705727A (nl) 1977-11-28
NL169182B NL169182B (nl) 1982-01-18
NL169182C true NL169182C (nl) 1982-06-16

Family

ID=9173528

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7705727,A NL169182C (nl) 1976-05-24 1977-05-24 Werkwijze voor de bereiding van een geneesmiddel met hypotensieve werking en verlaagde sedatieve neveneffecten op basis van fluorbevattende arylmethylaminoderivaten en werkwijze voor de bereiding van geneeskrachtige fluorbevattende arylmethylaminoderivaten, geschikt voor gebruik daarbij.

Country Status (21)

Country Link
US (3) US4267345A (nl)
JP (2) JPS584715B2 (nl)
AR (2) AR219296A1 (nl)
AT (1) AT350062B (nl)
AU (1) AU517715B2 (nl)
BE (1) BE854908A (nl)
CH (1) CH625795A5 (nl)
DE (1) DE2723464C2 (nl)
ES (1) ES459086A1 (nl)
FR (1) FR2358890A1 (nl)
GB (2) GB1564268A (nl)
GR (1) GR61659B (nl)
HU (1) HU177039B (nl)
IL (1) IL52137A (nl)
NL (1) NL169182C (nl)
NZ (1) NZ184175A (nl)
OA (1) OA05668A (nl)
PH (1) PH13880A (nl)
PT (1) PT66584B (nl)
SE (1) SE7705986L (nl)
SU (2) SU725561A3 (nl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2444673A1 (fr) * 1978-12-20 1980-07-18 Science Union & Cie Nouvelles trifluoroethylamines, leurs procedes d'obtention et leur emploi comme medicament
US4348247A (en) * 1979-02-26 1982-09-07 Rockwell International Corporation Method of fabricating a reinforced tubular structure
ATE29494T1 (de) * 1983-08-11 1987-09-15 Synthelabo Indol-derivate, verfahren zu deren herstellung und deren therapeutische anwendung.
JPH06312412A (ja) * 1992-06-10 1994-11-08 Nippon Hume Pipe Co Ltd 模様付き複合コンクリート製品およびその成形方法
AUPP020297A0 (en) * 1997-11-05 1997-11-27 University Of Melbourne, The A novel receptor, and compounds which bind thereto
CN1516586A (zh) * 2001-04-16 2004-07-28 �������Ǵ�ѧר������� 新型口服全身麻醉剂和抵抗代谢的抗惊厥药
EP2070923A1 (de) 2007-12-11 2009-06-17 Bayer CropScience AG Insektizide Iminoheterocyclen
UY32940A (es) * 2009-10-27 2011-05-31 Bayer Cropscience Ag Amidas sustituidas con halogenoalquilo como insecticidas y acaricidas
AR085509A1 (es) 2011-03-09 2013-10-09 Bayer Cropscience Ag Indol- y bencimidazolcarboxamidas como insecticidas y acaricidas
US9345247B2 (en) 2012-08-17 2016-05-24 Bayer Cropscience Ag Azaindole carboxylic acid amides and azaindole thiocarboxylic acid amides for use as insecticides and acaricides

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2889351A (en) * 1956-05-25 1959-06-02 Pfizer & Co C Therapeutic agents
US3626067A (en) * 1965-07-01 1971-12-07 Du Pont Substituted oxazolines, useful as pharmaceuticals
US3453284A (en) * 1966-01-19 1969-07-01 Du Pont Certain 2-(substituted-anilino)-2-oxazolines
DE1670751A1 (de) * 1966-09-27 1970-12-23 Bayer Ag Verfahren zur Herstellung von 2-Phenylamino-2-oxazolinen
US3622067A (en) * 1969-06-13 1971-11-23 Ok Partnership Ltd Document coder
BE754832A (fr) * 1969-08-14 1971-02-15 Beecham Group Ltd Iminazolines
USRE27133E (en) 1970-03-20 1971-06-01 Cdj)zco
US4102890A (en) * 1972-12-28 1978-07-25 Science-Union Et Cie, Societe Francaise De Recherche Medicale 2-Amino oxazolines and process for making the same
GB1453703A (en) * 1972-12-28 1976-10-27 Science Union & Cie Substituted cyclopropylmethylamines processes for their preparation and pharmaceutical compositions containing them
FR2269341B1 (nl) * 1974-04-30 1978-07-28 Castaigne Sa
GB1475513A (en) * 1974-06-20 1977-06-01 Science Union & Cie Benzylamine derivatives process for science union et cie benzylamine derivatives process for their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AU517715B2 (en) 1981-08-20
HU177039B (hu) 1981-06-28
NL7705727A (nl) 1977-11-28
SU725561A3 (ru) 1980-03-30
IL52137A (en) 1982-01-31
GR61659B (en) 1978-12-05
FR2358890B1 (nl) 1978-12-15
FR2358890A1 (fr) 1978-02-17
JPS584715B2 (ja) 1983-01-27
GB1564268A (en) 1980-04-02
JPS55127390A (en) 1980-10-02
CH625795A5 (nl) 1981-10-15
AU2537677A (en) 1978-11-30
PT66584B (fr) 1978-10-20
PT66584A (fr) 1977-06-01
US4315019A (en) 1982-02-09
SU791234A3 (ru) 1980-12-23
DE2723464A1 (de) 1977-12-08
IL52137A0 (en) 1977-07-31
BE854908A (fr) 1977-11-23
SE7705986L (sv) 1977-11-25
ES459086A1 (es) 1978-04-16
NL169182B (nl) 1982-01-18
AR219296A1 (es) 1980-08-15
DE2723464C2 (de) 1983-08-11
US4315020A (en) 1982-02-09
NZ184175A (en) 1979-07-11
US4267345A (en) 1981-05-12
PH13880A (en) 1980-10-24
ATA368277A (de) 1978-10-15
GB1564269A (en) 1980-04-02
AR222022A1 (es) 1981-04-15
AT350062B (de) 1979-05-10
JPS5325565A (en) 1978-03-09
OA05668A (fr) 1981-05-31

Similar Documents

Publication Publication Date Title
NL191793C (nl) Werkwijze voor de bereiding van een polypeptide, en van een farmaceutisch of veterinair preparaat.
NL7713618A (nl) Werkwijze voor de bereiding van een cosmetisch preparaat.
NL7614567A (nl) Werkwijze ter bereiding van een geneesmiddel en werkwijze ter bereiding van de geneeskrachtige verbinding.
NL7707785A (nl) Werkwijze voor de bereiding van n-gesubstitu- eerde chinazolinen met antihypertensieve wer- king, werkwijze voor de bereiding van een ge- neesmiddel met een dergelijke werking en ge- vormd geneesmiddel.
NL169182C (nl) Werkwijze voor de bereiding van een geneesmiddel met hypotensieve werking en verlaagde sedatieve neveneffecten op basis van fluorbevattende arylmethylaminoderivaten en werkwijze voor de bereiding van geneeskrachtige fluorbevattende arylmethylaminoderivaten, geschikt voor gebruik daarbij.
NL7704760A (nl) Werkwijze voor de bereiding van 4-aminopiperi- dinen, werkwijze voor de bereiding van een ge- neesmiddel met antihypertensieve werking en een dergelijk geneesmiddel.
NL7707263A (nl) Werkwijze voor het bereiden van een geneesmiddel en de onder toepassing van deze werkwijze verkregen gevormde geneesmiddelen.
NL7703237A (nl) Werkwijze voor de bereiding van een veterinair geneesmiddel.
NL7604164A (nl) Werkwijze voor de bereiding van benzofenonen met anti-allergische werking, werkwijze voor de be- reiding van een geneesmiddel met een dergelijke werking en een dergelijk geneesmiddel.
NL7704585A (nl) Werkwijze voor het bereiden van een genees- middel.
NL7708162A (nl) Werkwijze voor de bereiding van een farmaceu- tisch preparaat.
NL7712996A (nl) Werkwijze voor de bereiding van een farmaceu- tisch preparaat.
NL7711993A (nl) Werkwijze voor het bereiden van een geneesmiddel van hypoglycemische werking, alsmede het verkregen gevormde geneesmiddel.
NL7706614A (nl) Werkwijze voor het bereiden van een geneesmiddel, zo gevormd geneesmiddel en werkwijze voor het bereiden van geneeskrachtigm verbindingen.
NL186383C (nl) Werkwijze voor de bereiding van octahydroindolochinolizinederivaten en werkwijze voor de bereiding van een farmaceutisch preparaat met vaatverwijdende werking, alsmede gevormd farmaceutisch preparaat.
NL176674C (nl) Werkwijze ter bereiding van een geneesmiddel voor de behandeling van circulatiestoringen en werkwijze ter bereiding van de geneeskrachtige verbindingen.
NL7703236A (nl) Werkwijze voor de bereiding van een veterinair geneesmiddel.
NL7703239A (nl) Werkwijze voor de bereiding van een geneesmiddel met anti-ulcus en diuretische werking, een der- gelijk geneesmiddel en werkwijze voor de berei- ding van de werkzame verbindingen.
NL7704218A (nl) Corticoiden, werkwijze voor het bereiden daar- van, alsmede werkwijze voor het bereiden van een geneesmiddel met anti-inflammatorische werking.
NL7705718A (nl) Werkwijze voor de bereiding van een ontlatend scheidingsmiddel.
NL179053C (nl) N-gesubstitueerde moranolinederivaten, werkwijze voor de bereiding ervan, alsmede werkwijze voor de bereiding van een geneesmiddel met een dergelijk derivaat erin.
NL7711969A (nl) Werkwijze voor de bereiding van een farmaceu- tisch preparaat met allergie- en astmawerende werking.
NL7700424A (nl) Werkwijze voor de bereiding van een farmaceu- tisch preparaat.
NL7714628A (nl) Gedisubstitueerde piperazinen, werkwijze voor de bereiding daarvan en dergelijke piperazinen bevattende geneesmiddelen.
NL7701509A (nl) Werkwijze voor de bereiding van verbindingen met anti-arrythmische werking, werkwijze voor de be- reiding van een geneesmiddel met anti-arrythmische werking en een dergelijke geneesmiddel.

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee